成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 33332-28-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 33332-28-4
Chemical Structure| 33332-28-4
Structure of 33332-28-4 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 33332-28-4 ]

Related Doc. of [ 33332-28-4 ]

Alternatived Products of [ 33332-28-4 ]
Product Citations

Product Details of [ 33332-28-4 ]

CAS No. :33332-28-4 MDL No. :MFCD00055024
Formula : C4H4ClN3 Boiling Point : No data available
Linear Structure Formula :- InChI Key :JTPXVCKCLBROOJ-UHFFFAOYSA-N
M.W : 129.55 Pubchem ID :118458
Synonyms :

Calculated chemistry of [ 33332-28-4 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 31.45
TPSA : 51.8 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.42 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.11
Log Po/w (XLOGP3) : 0.95
Log Po/w (WLOGP) : 0.72
Log Po/w (MLOGP) : -0.45
Log Po/w (SILICOS-IT) : 0.98
Consensus Log Po/w : 0.66

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.8
Solubility : 2.07 mg/ml ; 0.016 mol/l
Class : Very soluble
Log S (Ali) : -1.62
Solubility : 3.07 mg/ml ; 0.0237 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.87
Solubility : 1.74 mg/ml ; 0.0135 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.02

Safety of [ 33332-28-4 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 33332-28-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 33332-28-4 ]
  • Downstream synthetic route of [ 33332-28-4 ]

[ 33332-28-4 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 544-97-8 ]
  • [ 33332-28-4 ]
  • [ 5521-56-2 ]
YieldReaction ConditionsOperation in experiment
28% at 105℃; for 16.25 h; A. 6-Methylpyrazine-2-ylamine. To a solution containing 6-chloro-2- pyrazineamine (5.0 g, 38.75 mmol) in 1,4-dioxane (70 mL) was added [1,3- bis(diphenylphosphino]Ni(II)Cl2 (2.10 g, 38.76 mmol), followed by drop-wise addition of dimethylzinc in toluene (38.75 mL, 2.0 M, 77.50 mmol), over 15 min. The solution was allowed stir at 105 °C for 16 hours. The solution was then condensed under reduced pressure, diluted with ethyl acetate and filtered through celite to remove the nickel salts. The resultant slurry was purified via Biotage silica gel chromatography (0-8percent methanol in dichloromethane) to afford the title compound as an orange solid (1.18 g, 28percent yield). MS (ESI) m/z 1 10.3 [M+ 1]+.
Reference: [1] Tetrahedron Letters, 2006, vol. 47, # 3, p. 341 - 344
[2] Patent: WO2008/51493, 2008, A2, . Location in patent: Page/Page column 101
[3] Patent: WO2008/83070, 2008, A1, . Location in patent: Page/Page column 85
[4] Patent: US2013/210818, 2013, A1, . Location in patent: Paragraph 0390
[5] Patent: WO2009/115486, 2009, A1, . Location in patent: Page/Page column 25-26
[6] Patent: WO2009/115572, 2009, A2, . Location in patent: Page/Page column 117-118
[7] Patent: WO2004/108692, 2004, A1, . Location in patent: Page 37-38
  • 2
  • [ 75-16-1 ]
  • [ 33332-28-4 ]
  • [ 5521-56-2 ]
Reference: [1] Patent: US2015/175616, 2015, A1, . Location in patent: Paragraph 0242; 0243
[2] Patent: WO2015/100217, 2015, A1, . Location in patent: Page/Page column 99
[3] Patent: WO2016/10809, 2016, A1, . Location in patent: Paragraph 0279
[4] Patent: WO2016/172117, 2016, A1, . Location in patent: Page/Page column 32-33
  • 3
  • [ 33332-28-4 ]
  • [ 5158-46-3 ]
  • [ 5521-56-2 ]
Reference: [1] Tetrahedron Letters, 2006, vol. 47, # 3, p. 341 - 344
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 33332-28-4 ]

Chlorides

Chemical Structure| 1259479-81-6

[ 1259479-81-6 ]

5-Chloropyrazine-2,3-diamine

Similarity: 1.00

Chemical Structure| 61655-72-9

[ 61655-72-9 ]

6-Chloro-N,N-dimethylpyrazin-2-amine

Similarity: 0.80

Chemical Structure| 4858-85-9

[ 4858-85-9 ]

2,3-Dichloropyrazine

Similarity: 0.76

Chemical Structure| 95-58-9

[ 95-58-9 ]

2-Chloro-3-methylpyrazine

Similarity: 0.64

Chemical Structure| 19745-07-4

[ 19745-07-4 ]

2,5-Dichloropyrazine

Similarity: 0.64

Amines

Chemical Structure| 1259479-81-6

[ 1259479-81-6 ]

5-Chloropyrazine-2,3-diamine

Similarity: 1.00

Chemical Structure| 61655-72-9

[ 61655-72-9 ]

6-Chloro-N,N-dimethylpyrazin-2-amine

Similarity: 0.80

Chemical Structure| 6863-73-6

[ 6863-73-6 ]

3-Chloropyrazin-2-amine

Similarity: 0.61

Chemical Structure| 1370411-48-5

[ 1370411-48-5 ]

Pyrazine-2,6-diamine hydrochloride

Similarity: 0.57

Chemical Structure| 45644-21-1

[ 45644-21-1 ]

2-Amino-6-chloropyridine

Similarity: 0.56

Related Parent Nucleus of
[ 33332-28-4 ]

Pyrazines

Chemical Structure| 1259479-81-6

[ 1259479-81-6 ]

5-Chloropyrazine-2,3-diamine

Similarity: 1.00

Chemical Structure| 61655-72-9

[ 61655-72-9 ]

6-Chloro-N,N-dimethylpyrazin-2-amine

Similarity: 0.80

Chemical Structure| 4858-85-9

[ 4858-85-9 ]

2,3-Dichloropyrazine

Similarity: 0.76

Chemical Structure| 95-58-9

[ 95-58-9 ]

2-Chloro-3-methylpyrazine

Similarity: 0.64

Chemical Structure| 19745-07-4

[ 19745-07-4 ]

2,5-Dichloropyrazine

Similarity: 0.64

; ;